The clinical course of idiopathic membranous nephropathy - PubMed (original) (raw)

. 1973 Oct;48(10):697-712.

• PMID: 4745542

The clinical course of idiopathic membranous nephropathy

D T Erwin et al. Mayo Clin Proc. 1973 Oct.

No abstract available

PubMed Disclaimer

Similar articles

• Membranous glomerulonephritis: long-term serial observations on clinical course and morphology.
  Franklin WA, Jennings RB, Earle DP. Franklin WA, et al. Kidney Int. 1973 Jul;4(1):36-56. doi: 10.1038/ki.1973.78. Kidney Int. 1973. PMID: 4723993 No abstract available.
• [Recovery of normal ultrastructure in 2 cases of primary glomerulonephritis with diffuse extra-membranous deposits].
  Bariéty J, Samarcq P, Lagrue G, Fritel D, Milliez P. Bariéty J, et al. Presse Med (1893). 1968 Nov 27;76(46):2179-82. Presse Med (1893). 1968. PMID: 4888396 French. No abstract available.
• Extramembranous glomerulonephritis in children: report of 50 cases.
  Habib R, Kleinknecht C, Gubler MC. Habib R, et al. J Pediatr. 1973 May;82(5):754-66. doi: 10.1016/s0022-3476(73)80063-0. J Pediatr. 1973. PMID: 4572936 No abstract available.
• [Membranous nephropathy].
  Passos EM, Legallicier B, Godin M. Passos EM, et al. Rev Prat. 2003 Nov 30;53(18):2033-8. Rev Prat. 2003. PMID: 15008218 Review. French.
• [Idiopathic membranous nephropathy].
  Ponticelli C. Ponticelli C. Minerva Nefrol. 1983 Jan-Mar;30(1):7-10. Minerva Nefrol. 1983. PMID: 6341889 Review. Italian. No abstract available.

Cited by

• Membranous nephropathy: pathogenesis and treatments.
  Wang M, Yang J, Fang X, Lin W, Yang Y. Wang M, et al. MedComm (2020). 2024 Jun 29;5(7):e614. doi: 10.1002/mco2.614. eCollection 2024 Jul. MedComm (2020). 2024. PMID: 38948114 Free PMC article. Review.
• Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia.
  Scolari F, Alberici F, Mescia F, Delbarba E, Trujillo H, Praga M, Ponticelli C. Scolari F, et al. Front Immunol. 2022 Mar 1;13:789713. doi: 10.3389/fimmu.2022.789713. eCollection 2022. Front Immunol. 2022. PMID: 35300332 Free PMC article. Review.
• Clinical significance of glomerular C3 deposition in primary membranous nephropathy.
  Oto OA, Demir E, Mirioglu S, Dirim AB, Ozluk Y, Cebeci E, Basturk T, Ucar AR, Soltanova L, Nuriyev K, Kilicaslan I, Yazici H, Caliskan Y. Oto OA, et al. J Nephrol. 2021 Apr;34(2):581-587. doi: 10.1007/s40620-020-00915-w. Epub 2021 Jan 2. J Nephrol. 2021. PMID: 33387338
• A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti-Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients.
  Cantarelli C, Jarque M, Angeletti A, Manrique J, Hartzell S, O'Donnell T, Merritt E, Laserson U, Perin L, Donadei C, Anderson L, Fischman C, Chan E, Draibe J, Fulladosa X, Torras J, Riella LV, La Manna G, Fiaccadori E, Maggiore U, Bestard O, Cravedi P. Cantarelli C, et al. Kidney Int Rep. 2020 Aug 1;5(10):1764-1776. doi: 10.1016/j.ekir.2020.07.028. eCollection 2020 Oct. Kidney Int Rep. 2020. PMID: 33102969 Free PMC article.
• Immune-Monitoring Disease Activity in Primary Membranous Nephropathy.
  Cravedi P, Jarque M, Angeletti A, Favà À, Cantarelli C, Bestard O. Cravedi P, et al. Front Med (Lausanne). 2019 Nov 8;6:241. doi: 10.3389/fmed.2019.00241. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31788474 Free PMC article. Review.

MeSH terms

Substances